“Our first foray into the VC world was via the 2004 Bio-Life-Tech Conference at which we presented. It was a great training ground for the challenges that lay ahead. We got great tips on targeting our audience, presentation style and sustaining the attention of potential investors. ESE has been a very helpful resource to us,” said Adrienne Choma, President and COO of Saladax Biomedical, Inc. and presenter at Bio-Life-Tech 2004 and Early Stage East 2006.
Saladax Biomedical is developing innovative, patented tests which measure chemotherapy blood levels, thus allowing oncologists to adjust and personalize the dose being administered to each individual cancer patient. Clinical research has shown that this Personalized Chemotherapy Management (PCM) approach helps achieve more


More Details